More News

05 Oct 2017 Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics
05 Oct 2017 AMR Centre deal with Medivir targets superbug time-bomb
05 Oct 2017 Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments
05 Oct 2017 Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
04 Oct 2017 Palleon Pharmaceuticals Raises $47.6 Million to Develop Glycoimmune Checkpoint Inhibitors, a New Class of Medicines Designed to Overcome Resistance to First-Generation Immuno-Oncology Drugs
04 Oct 2017 Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors
04 Oct 2017 Nimbus Therapeutics and Celgene Enter Long-Term Strategic Immunology Alliance to Develop Programs for Patients with Autoimmune Disorders
04 Oct 2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
04 Oct 2017 Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
03 Oct 2017 Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors
03 Oct 2017 Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted Radioligand Therapy for Development in Prostate Cancer
29 Sep 2017 Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge
28 Sep 2017 Thermalin Announces: Collaboration with Sanofi to Develop Next Generation Insulin Therapies
28 Sep 2017 OSE Immunotherapeutics Signs a License Option Agreement with Inserm to Develop a New Cancer Immunotherapy Targeting Myeloid Cells
28 Sep 2017 Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for Clinical Target Validation in Inflammatory Bowel Disease
28 Sep 2017 Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
28 Sep 2017 Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets
28 Sep 2017 Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China
26 Sep 2017 Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice
26 Sep 2017 Genocea Announces Strategic Shift to Immuno-oncology and the Development of Neoantigen Cancer Vaccines
26 Sep 2017 Glythera Licenses Novel Payload Class from Cancer Research UK for the Development of Next-Generation Antibody Drug Conjugates
26 Sep 2017 SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs
25 Sep 2017 eTheRNA immunotherapies Awarded €1 Million Grant From Flanders Innovation & Entrepreneurship to Further Upgrade its State-of-the-art Production Process for TriMix mRNA Immunotherapies
21 Sep 2017 Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
21 Sep 2017 Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing